VERNON RAYFORD: Open Payments
NPI 1053548545 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,477 in 22 payments from 8 companies in 2025. Trend: 2023 $217 · 2024 $181 · 2025 $6,477
Speaker / faculty: $3,001Travel & lodging: $1,682Consulting: $1,500Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 14 | $6,291 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $60 |
| La Jolla Pharmaceutical Company | 2 | $36 |
| Medtronic, Inc. | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Tandem Diabetes Care, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $16 |
Products named: Omnipod, GIAPREZA, MINIMED 780G, VOWST, INJECTAFER, t:slim X2 Insulin Pump with Control-IQ, ELIQUIS.
Industry payments across MS — which companies pay providers there.
